AI-Augmented Medtech Quality Management Systems Market Report 2026

The artificial intelligence (AI)-augmented medtech quality management systems market size has grown rapidly in recent years. It will grow from $0.84 billion in 2025 to $1 billion in 2026 at a compound annual growth rate (CAGR) of 18.4%. The growth in the historic period can be attributed to increasing medical device recalls, tightening global regulatory frameworks, manual quality management inefficiencies, globalization of medtech supply chains, rising documentation and compliance workload.

The artificial intelligence (AI)-augmented medtech quality management systems market size is expected to see rapid growth in the next few years. It will grow to $1.98 billion by 2030 at a compound annual growth rate (CAGR) of 18.7%. The growth in the forecast period can be attributed to shift toward predictive quality management adoption, increasing automation in compliance monitoring, growth of personalized medical devices requiring adaptive qms, expansion of real-time quality performance analytics, rising focus on zero-defect manufacturing culture. Major trends in the forecast period include regulatory convergence & stringent medtech compliance requirements, rise of risk-based quality management systems, supplier quality assurance & end-to-end traceability enhancement, post-market surveillance & adverse event monitoring expansion, standardization of audit readiness & documentation control processes.

The increasing adoption of cloud-based solutions is expected to drive the growth of the artificial intelligence (AI)-augmented MedTech quality management systems market in the coming years. Cloud-based solutions refer to software and services delivered over the internet that provide on-demand access to data storage, computing resources, and applications without requiring on-premises infrastructure. The adoption of cloud-based solutions is rising due to their scalability, cost efficiency, remote accessibility, and capability to support real-time data sharing across geographically distributed teams. In AI-augmented MedTech quality management systems, cloud-based solutions enable seamless integration of quality processes, centralized data management, and deployment of advanced AI capabilities such as predictive analytics and automated compliance monitoring. For instance, in March 2024, according to Flexera, a US-based computer software company, multi-cloud usage increased from 87% in the previous year to 89%, reflecting a growing preference for cloud-based infrastructures. Therefore, the increasing adoption of cloud-based solutions is driving the growth of the artificial intelligence (AI)-augmented MedTech quality management systems market.

Leading companies operating in the artificial intelligence (AI)-augmented medtech quality management systems market are focusing on platform enhancements and intelligent automation capabilities such as integrated recall management and end-to-end quality process automation to improve compliance efficiency and streamline quality operations. Integrated recall management and automated quality workflows refer to advanced system capabilities that enable seamless coordination of field actions, complaint handling, corrective and preventive actions (CAPA), risk management, and change control within a unified digital environment. For example, in September 2024, Veeva Systems, a US-based provider of cloud-based software solutions for the life sciences industry, announced enhancements to its Veeva Vault QMS platform, introducing new field actions and recall management capabilities. This update enables end-to-end automation across key quality processes, improving operational visibility, accuracy, and regulatory compliance. Additionally, the enhancements support the integration of data-driven and AI-enabled functionalities, allowing organizations to achieve more intelligent, connected, and efficient quality management processes.

In April 2024, Clarivate Plc, a UK-based provider of data intelligence and analytics solutions, acquired Global QMS Inc. for an undisclosed value. Through this acquisition, Clarivate enhanced its AI-augmented quality management and regulatory compliance capabilities within the life sciences and healthcare sector, incorporating Global Q’s Optiqs360 Digital platform, which features advanced automation for regulatory reporting, quality management, and supply chain insights, into its portfolio of solutions to streamline end-to-end quality processes. Global QMS Inc. is a US-based provider of cloud-based workflow and regulatory quality management software serving life sciences, medtech, and biotech organizations.

Major companies operating in the artificial intelligence (AI)-augmented medtech quality management systems market are Oracle Corporation, Honeywell International Inc., IQVIA Holdings Inc., Dassault Systèmes SE, Siemens Industry Software Inc., Veeva Systems Inc., PTC Inc., CitiusTech Healthcare Technology Private Limited, MetricStream Inc., MasterControl Inc., Arena Solutions Inc., ComplianceQuest Inc., Greenlight Guru Inc., Propel Software Solutions Inc., Qualio Inc., Intellect Design Arena Limited, Ketryx Corporation, Dot Compliance Ltd., AssurX Inc., Ideagen Limited, qmsWrapper LLC, MedQdoc Inc.

North America was the dominating region in the artificial intelligence (AI)-augmented medtech quality management systems market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the artificial intelligence (AI)-augmented medtech quality management systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the artificial intelligence (AI)-augmented medtech quality management systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-augmented medtech quality management systems market consists of revenues earned by entities by providing services such as AI-driven quality monitoring, automated regulatory compliance management, predictive risk analysis, anomaly detection in manufacturing and clinical data, and intelligent document and audit management. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-augmented medtech quality management systems market also includes sales of AI-powered quality management software, compliance monitoring platforms, predictive analytics tools, automated audit and documentation management systems, and data-driven risk assessment solutions designed to improve quality control and regulatory adherence in medical technology processes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.